// App-Quantinova.ai

: Argx-110 for Treatment of CD70-Positive Advanced Cutaneous T-Cell Lymphoma in a Phase 1/2 Clinical Trial

Researchers

Presenter

  • Martine Bagot

Principal Investigators

  • Pier Luigi Zinzani

  • Fritz Offner

  • Franck Morschhauser

  • Jean-Marie Michot

  • Vincent Ribrag

  • Maxime Battistella

  • Helene Moins

  • Angelica Calleri

  • Stphane Dalle

  • Marie Beylot-Barry

  • Karen Zwaenepoel

  • Koen De Winnie

  • Anne Marie-Cardine

  • Jean-Michel Cayuela

  • Valentina Tabanelli

  • Giovanna Motta

  • Federica Melle

  • Anna Hultberg

  • Domenica Gandini

  • Teresa Marafioti

  • Mahan Moshir

  • Tim Delahaye

  • Piotr Zabrocki

  • Karen Silence

  • Luc Van Rompaey

  • Armand Bensussan

  • Hans De Haard

  • Patrick Pauwels

  • Nicolas Leupin

  • Stefano A. Pileri

Medical Centers

  • Hopital Saint-Louis, AP-HP, Universite Paris , Paris, France

  • Hospital Jules Bordet, Bruxelles, France

  • Istituto di Ematologia, Bologna, Italy

  • Ghent University Hospital, Ghent, Belgium

  • Centre Hospitalier Regional Universitaire Lille, Lille, France

  • Gustave Roussy Cancer Campus, Villejuif, France

  • Gustave Roussy, Universite Paris-Saclay, Villejuif, France

  • INSERM U1165, Universite Paris 7, AP-HP Hopital Saint Louis, Paris, FRA

  • INSERM UMR-1160, Institut Universitaire D'Hematologie, Paris, FRA

  • Unit of Hematopathology,European Institute of Oncology,Milano,Italy

  • Hospices Civils de Lyon, Claude Bernard Lyon 1 University, Lyon, France

  • CHU de Bordeaux, Service de Dermatologie; Hôpital Saint-André, Bordeaux, France

  • University Institution Antwerp, Antwerp, Belgium

  • University Hospital Antwerp, Edegem, Antwerp, Belgium

  • Laboratory of hematology and EA, University Hospital Saint-Louis, Paris, France

  • Laboratory of Hematology, University Hospital Saint-Louis, AP-HP, Paris & GBMHM External Quality Assessment platform, Paris, France

  • Argen-X, Zwijnaarde, Belgium

  • Department of Histopathology, Imperial College London, London, United Kingdom

  • argenx, Zwijnaarde, BEL

  • University Paris, Hopital Saint-Louis, Paris, France

Locations

  • France

  • Italy

  • Belgium

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Cutaneous T-cell lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • ARGX-110

Outcome

  • N/A

Study Design

  • Randomized

  • Pharmacokinetics

  • Open Label

  • Multicenteric

Phase

  • I/II

Study Id's

  • NCT01813539

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved